SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Richard B. Freeman, A decade of model for end-stage liver disease, Current Opinion in Organ Transplantation, 2012, 17, 3, 211

    CrossRef

  2. 2
    David Fuks, Safi Dokmak, Valérie Paradis, Momar Diouf, François Durand, Jacques Belghiti, Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: An intention-to-treat analysis, Hepatology, 2012, 55, 1
  3. 3
    EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma, European Journal of Cancer, 2012, 48, 5, 599

    CrossRef

  4. 4
    Jinyang Gu, Jianling Bai, Xiaolei Shi, Jianxin Zhou, Yudong Qiu, Yafu Wu, Chunping Jiang, Xitai Sun, Fanggui Xu, Yue Zhang, Yitao Ding, Efficacy and safety of liver transplantation in patients with cholangiocarcinoma: A systematic review and meta-analysis, International Journal of Cancer, 2012, 130, 9
  5. 5
    F. Cauchy, D. Fuks, J. Belghiti, HCC: current surgical treatment concepts, Langenbeck's Archives of Surgery, 2012, 397, 5, 681

    CrossRef

  6. 6
    Alejandro Forner, Josep M Llovet, Jordi Bruix, Hepatocellular carcinoma, The Lancet, 2012, 379, 9822, 1245

    CrossRef

  7. 7
    Zakiyah Kadry, Eric W. Schaefer, Tadahiro Uemura, Ali Riaz Shah, Ian Schreibman, Thomas R. Riley, Impact of geographic disparity on liver allocation for hepatocellular cancer in the United States, Journal of Hepatology, 2012, 56, 3, 618

    CrossRef

  8. 8
    Marina Knight, Kerri Barber, Alex Gimson, Dave Collett, James Neuberger, Implications of changing the minimal survival benefit in liver transplantation, Liver Transplantation, 2012, 18, 5
  9. 9
    M.B. Majella Doyle, Neeta Vachharajani, Erin Maynard, Surendra Shenoy, Christopher Anderson, Jason R. Wellen, Jeffrey A. Lowell, William C. Chapman, Liver Transplantation for Hepatocellular Carcinoma: Long-Term Results Suggest Excellent Outcomes, Journal of the American College of Surgeons, 2012,

    CrossRef

  10. 10
    Carlos Rodríguez de Lope, Silvia Tremosini, Alejandro Forner, María Reig, Jordi Bruix, Management of HCC, Journal of Hepatology, 2012, 56, S75

    CrossRef

  11. 11
    Jennifer Guy, Robin K. Kelley, John Roberts, Robert Kerlan, Francis Yao, Norah Terrault, Multidisciplinary Management of Hepatocellular Carcinoma, Clinical Gastroenterology and Hepatology, 2012, 10, 4, 354

    CrossRef

  12. 12
    Hari Nathan, Dorry L. Segev, Skye C. Mayo, Michael A. Choti, Andrew M. Cameron, Christopher L. Wolfgang, Kenzo Hirose, Barish H. Edil, Richard D. Schulick, Timothy M. Pawlik, National trends in surgical procedures for hepatocellular carcinoma: 1998-2008, Cancer, 2012, 118, 7
  13. 13
    Robin K. Kelley, Francis Yao, Salvage liver transplantation for recurrent hepatocellular carcinoma after radiofrequency ablation: A new strategy?, Journal of Hepatology, 2012, 56, 1, 14

    CrossRef

  14. 14
    Douglas M. Heuman, HoChong S. Gilles, Cynthia Solomon, Jasmohan S. Bajaj, Should a radiological diagnosis of hepatocellular carcinoma be routinely confirmed by a biopsy? NO, European Journal of Internal Medicine, 2012, 23, 1, 37

    CrossRef

  15. 15
    Emmet B. Keeffe, Goldman's Cecil Medicine, 2012,

    CrossRef

  16. 16
    Stevan A. Gonzalez, Emmet B. Keeffe, Handbook of Liver Disease, 2012,

    CrossRef

  17. 17
    Stefan G. Hübscher, Andrew D. Clouston, MacSween's Pathology of the Liver, 2012,

    CrossRef

  18. 18
    Scott W. Biggins, Zakim and Boyer's Hepatology, 2012,

    CrossRef

  19. 19
    Jorge A. Marrero, Zakim and Boyer's Hepatology, 2012,

    CrossRef

  20. 20
    Heather M. Patton, Benjamin F. Johnson, Emmanuil Smorodinsky, Claude B. Sirlin, Zakim and Boyer's Hepatology, 2012,

    CrossRef

  21. 21
    Alessandro Vitale, Rafael Ramirez Morales, Giacomo Zanus, Fabio Farinati, Patrizia Burra, Paolo Angeli, Anna Chiara Frigo, Paolo Del Poggio, Gianludovico Rapaccini, Maria Anna Di Nolfo, Luisa Benvegnù, Marco Zoli, Franco Borzio, Edoardo Giovanni Giannini, Eugenio Caturelli, Maria Chiaramonte, Franco Trevisani, Umberto Cillo, Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study, The Lancet Oncology, 2011, 12, 7, 654

    CrossRef

  22. 22
    A. Cucchetti, M. Cescon, V. Bertuzzo, E. Bigonzi, G. Ercolani, M. C. Morelli, M. Ravaioli, A. D. Pinna, Can the Dropout Risk of Candidates with Hepatocellular Carcinoma Predict Survival after Liver Transplantation?, American Journal of Transplantation, 2011, 11, 8
  23. 23
    Alessandro Cucchetti, Matteo Cescon, Giorgio Ercolani, Maria Cristina Morelli, Massimo Del Gaudio, Matteo Zanello, Antonio Daniele Pinna, Comparison between observed survival after resection of transplantable hepatocellular carcinoma and predicted survival after listing through a Markov model simulation, Transplant International, 2011, 24, 8
  24. 24
    Chia-Yang Hsu, Yi-Hsiang Huang, Yi-You Chiou, Chien-Wei Su, Han-Chieh Lin, Rheun-Chuan Lee, Jen-Huey Chiang, Teh-Ia Huo, Fa-Yauh Lee, Shou-Dong Lee, Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: A propensity score analysis, Liver Transplantation, 2011, 17, 5
  25. 25
    Mauricio F. Silva, Morris Sherman, Criteria for liver transplantation for HCC: What should the limits be?, Journal of Hepatology, 2011, 55, 5, 1137

    CrossRef

  26. 26
    Francis Y. Yao, Stefan Breitenstein, Christoph E. Broelsch, Jean-Francois Dufour, Morris Sherman, Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?, Liver Transplantation, 2011, 17, S2
  27. 27
    Rita Golfieri, Alberta Cappelli, Alessandro Cucchetti, Fabio Piscaglia, Maria Carpenzano, Eugenia Peri, Matteo Ravaioli, Antonia D'Errico-Grigioni, Antonio Daniele Pinna, Luigi Bolondi, Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas, Hepatology, 2011, 53, 5
  28. 28
    Masato Fujiki, Federico Aucejo, Richard Kim, General overview of neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: necessity or option?, Liver International, 2011, 31, 8
  29. 29
    Kenneth Washburn, Glenn Halff, Hepatocellular carcinoma and liver transplantation, Current Opinion in Organ Transplantation, 2011, 16, 3, 297

    CrossRef

  30. 30
    Jeong Min Lee, Franco Trevisani, Valerie Vilgrain, Christoph Wald, Imaging diagnosis and staging of hepatocellular carcinoma, Liver Transplantation, 2011, 17, S2
  31. 31
    Pietro Majno, Riccardo Lencioni, Françoise Mornex, Nicolas Girard, Ronnie T. Poon, Daniel Cherqui, Is the treatment of hepatocellular carcinoma on the waiting list necessary?, Liver Transplantation, 2011, 17, S2
  32. 32
    Mario Angelico, Umberto Cillo, Stefano Fagiuoli, Antonio Gasbarrini, Caius Gavrila, Tania Marianelli, Alessandro Nanni Costa, Alessandra Nardi, Mario Strazzabosco, Patrizia Burra, Salvatore Agnes, Umberto Baccarani, Fulvio Calise, Michele Colledan, Oreste Cuomo, Luciano De Carlis, Matteo Donataccio, Giuseppe M. Ettorre, Giorgio E. Gerunda, Bruno Gridelli, Luigi Lupo, Vincenzo Mazzaferro, Antonio Pinna, Andrea Risaliti, Mauro Salizzoni, Giuseppe Tisone, Umberto Valente, Giorgio Rossi, Massimo Rossi, Fausto Zamboni, Liver Match, a prospective observational cohort study on liver transplantation in Italy: Study design and current practice of donor–recipient matching, Digestive and Liver Disease, 2011, 43, 2, 155

    CrossRef

  33. 33
    C. Toso, G. Mentha, P. Majno, Liver Transplantation for Hepatocellular Carcinoma: Five Steps to Prevent Recurrence, American Journal of Transplantation, 2011, 11, 10
  34. 34
    David M. Levi, Seigo Nishida, Liver Transplantation for Hepatocellular Carcinoma: Lessons Learned and Future Directions, Clinics in Liver Disease, 2011, 15, 4, 717

    CrossRef

  35. 35
    Kathryn J. Fowler, Jeffrey J. Brown, Vamsi R. Narra, Magnetic resonance imaging of focal liver lesions: Approach to imaging diagnosis, Hepatology, 2011, 54, 6
  36. 36
    Tsung-Ming Chen, Chun-Che Lin, Pi-Teh Huang, Chen-Fan Wen, Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation, Journal of Gastroenterology and Hepatology, 2011, 26, 5
  37. 37
    Vincenzo Mazzaferro, Sherrie Bhoori, Carlo Sposito, Marco Bongini, Martin Langer, Rosalba Miceli, Luigi Mariani, Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experience, Liver Transplantation, 2011, 17, S2
  38. 38
    Gonzalo Sapisochin, Nicholas Fidelman, John P. Roberts, Francis Y. Yao, Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma, Liver Transplantation, 2011, 17, 8
  39. 39
    Sumeet K. Asrani, W. Ray Kim, Model for End-Stage Liver Disease: End of the First Decade, Clinics in Liver Disease, 2011, 15, 4, 685

    CrossRef

  40. 40
    Claire Francoz, Jacques Belghiti, Denis Castaing, Olivier Chazouillères, Jean-Charles Duclos-Vallée, Christophe Duvoux, Jan Lerut, Yves-Patrice Le Treut, Richard Moreau, Ameet Mandot, Georges Pageaux, Didier Samuel, Dominique Thabut, Dominique Valla, François Durand, Model for end-stage liver disease exceptions in the context of the french model for end-stage liver disease score–based liver allocation system, Liver Transplantation, 2011, 17, 10
  41. 41
    Kenneth Washburn, Model for end-stage liver disease exceptions: Proceed with caution, Liver Transplantation, 2011, 17, 10
  42. 42
    T. Piardi, F. Gheza, B. Ellero, M. L. Woehl-Jaegle, D. Ntourakis, M. Cantu, E. Marzano, M. Audet, P. Wolf, Patrick Pessaux, Number and Tumor Size Are Not Sufficient Criteria to Select Patients for Liver Transplantation for Hepatocellular Carcinoma, Annals of Surgical Oncology, 2011, 19, 6, 2020

    CrossRef

  43. 43
    S. T. Fan, R. T. P. Poon, C. Yeung, C. M. Lam, C. M. Lo, W. K. Yuen, K. K. C. Ng, C. L. Liu, S. C. Chan, Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria, British Journal of Surgery, 2011, 98, 9
  44. 44
    Alessandro Cucchetti, Matteo Cescon, Eleonora Bigonzi, Fabio Piscaglia, Rita Golfieri, Giorgio Ercolani, Maria Cristina Morelli, Matteo Ravaioli, Antonio Daniele Pinna, Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy, Liver Transplantation, 2011, 17, 11
  45. 45
    Emilio Quaia, Solid focal liver lesions indeterminate by contrast-enhanced CT or MR imaging: the added diagnostic value of contrast-enhanced ultrasound, Abdominal Imaging, 2011,

    CrossRef

  46. 46
    A. N. Gordon-Weeks, A. Snaith, T. Petrinic, P. J. Friend, A. Burls, M. A. Silva, Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria, British Journal of Surgery, 2011, 98, 9
  47. 47
    Shaheed Merani, Pietro Majno, Norman M. Kneteman, Thierry Berney, Philippe Morel, Gilles Mentha, Christian Toso, The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma, Journal of Hepatology, 2011, 55, 4, 814

    CrossRef

  48. 48
    James Neuberger, The management of patients awaiting liver transplantation, Indian Journal of Transplantation, 2011, 5, 2, 66

    CrossRef

  49. 49
    Norman Kneteman, Tito Livraghi, David Madoff, Eduardo de Santibañez, Michael Kew, Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation, Liver Transplantation, 2011, 17, S2
  50. 50
    Didier Samuel, Massimo Colombo, Hachem El-Serag, Rodolphe Sobesky, Nigel Heaton, Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma, Liver Transplantation, 2011, 17, S2
  51. 51
    Kim M. Olthoff, Alejandro Forner, Stefan Hübscher, John Fung, What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?, Liver Transplantation, 2011, 17, S2
  52. 52
    Fabio Piscaglia, Alessandro Cucchetti, Luigi Bolondi, “Survival benefit”: The final destination, with still a long way to go, Digestive and Liver Disease, 2010, 42, 9, 608

    CrossRef

  53. 53
    Tito Livraghi, Giorgio Brambilla, Carlo Carnaghi, Maurizio A. Tommasini, Guido Torzilli, Is it time to reconsider the BCLC/AASLD therapeutic flow-chart?, Journal of Surgical Oncology, 2010, 102, 7
  54. 54
    Pietro Majno, Gilles Mentha, Christian Toso, Transplantation for hepatocellular carcinoma: Management of patients on the waiting list, Liver Transplantation, 2010, 16, S2
  55. 55
    Maria Reig, Alejandro Forner, Jordi Bruix, Hepatocellular Carcinoma,
  56. 56
    Myron Schwartz, Transplant Considerations,